If they reflect causal associations and are not due to chance, these findings could have implications for public health interventions: IGF-I has been promoted for treating diabetes, osteoporosis and insulin resistance [40]; however, lifestyle and pharmacological interventions are also being considered to reduce circulating levels of IGF-1 in order to prevent cancer [41]. This evidence concerns the gene IGF1 and diabetes mellitus.